s-nitroso-n-acetylpenicillamine has been researched along with Diabetic Angiopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danser, AH; de Vries, R; Dekker, R; Duncker, DJ; Eringa, EC; Koopmans, SJ; Sorop, O; van Beusekom, HM; van den Heuvel, M; van der Giessen, WJ | 1 |
| Bucala, R; Cerami, A; Hogan, M | 1 |
2 other study(ies) available for s-nitroso-n-acetylpenicillamine and Diabetic Angiopathies
| Article | Year |
|---|---|
Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes.
Topics: Animals; Blood Glucose; Bradykinin; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Progression; Dose-Response Relationship, Drug; Endothelin-1; Endothelium, Vascular; Male; Nitric Oxide; Nitric Oxide Donors; Receptors, Endothelin; S-Nitroso-N-Acetylpenicillamine; Swine; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2012 |
Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.
Topics: Animals; Cell Division; Cells, Cultured; Collagen; Diabetic Angiopathies; Diabetic Nephropathies; Glycosylation; Mice; Nitric Oxide; Penicillamine; Proteins; S-Nitroso-N-Acetylpenicillamine | 1992 |